NayoungKimMD

Allergy & Immunology • Sacramento, CA

Physician

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

Office
2345 Fair Oaks Blvd
Suite 14
Sacramento, CA 95825
Phone+1 916-480-6659

Summary

Dr. Nayoung Kim is an Allergy & Immunology specialist based in Sacramento, CA. She completed her medical education at Northwestern University The Feinberg School of Medicine in 2002, followed by a residency in Internal Medicine at McGaw Medical Center of Northwestern University, and a fellowship in Allergy and Immunology at the National Institutes of Health Clinical Center. Dr. Kim has contributed to research, with her publication in the Archives of Pharmacal Research being cited 36 times. She has been involved in multiple clinical trials focusing on gastroenterology-related topics. In 2011, she received the Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services.

Education & Training

National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 2005 - 2008
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2002 - 2005
Northwestern University The Feinberg School of MedicineClass of 2002

Certifications & Licensure

CA State Medical License 2008 - 2026
MD State Medical License 2005 - 2008
IL State Medical License 2002 - 2005
American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

Nociceptors, Neurotrophic Factors and Cytokine Expression in Gastroesophageal Reflux Disease Start of enrollment: 2013 Mar 01
Completed
Not Applicable
Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea Start of enrollment: 2014 Jul 01
Completed
Not Applicable
Gut Hormone, Nociceptors, Neurotrophic Factors Expression in Functional Dyspepsia Start of enrollment: 2011 Feb 01
Completed
Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients Start of enrollment: 2006 Feb 01
Completed
OLGA and OLGIM Stage System for Gastric Cancer Start of enrollment: 2006 Feb 01
Completed
Neurotrophic Factors, Tight Junction Proteins, and Cytokines in IBS Start of enrollment: 2009 Jun 01
Completed
Not Applicable
Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study Start of enrollment: 2019 Jan 30
Completed
Long-term Follow-up of Interleukin-1B and H+,K+-ATPase mRNA Expression After Helicobacter Pylori Eradication Start of enrollment: 2006 Feb 01
Completed
Join now to see all

Publications & Presentations

PubMed

36 citations
Butein sensitizes human leukemia cells to apoptosis induced by tumor necrosis factor-related apoptosis inducing ligand (TRAIL)
Nayoung Kim
Archives of Pharmacal Research. 2008-09-01

Press Mentions

Predictors of Prognosis in IBD PatientsDecember 15th, 2022